Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Clears Tysabri For Limited Clinical Use

Feb 15 2006

• By Kathryn Phelps

Related Content

Tysabri To Go Before Advisory Committee On March 7

Jan 23 2006

Biogen Idec/Elan Resubmit Tysabri With New Risk Management Program

Sep 26 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window